| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 49,978,038,056.97 | 30,736,059,514.63 | 20,824,982,593.67 | 11,216,532,204.24 |
| 收到的税费返还 | 1,071,870,045.22 | 672,588,586.35 | 397,850,949.95 | 106,821,748.42 |
| 收到其他与经营活动有关的现金 | 6,900,576,885.86 | 5,743,543,375.82 | 4,206,054,470.39 | 2,315,168,870.4 |
| 经营活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
| 经营活动现金流入小计 | 57,950,484,988.05 | 37,152,191,476.8 | 25,428,888,014.01 | 13,638,522,823.06 |
| 购买商品、接受劳务支付的现金 | 25,227,355,121.22 | 19,647,364,619.65 | 14,628,683,951.08 | 7,874,817,788.65 |
| 支付给职工以及为职工支付的现金 | 3,571,299,992.74 | 2,325,555,756.16 | 1,577,467,967.37 | 832,213,622.45 |
| 支付的各项税费 | 6,910,121,506.84 | 5,950,960,651.99 | 4,884,151,470.14 | 2,293,369,138.26 |
| 支付其他与经营活动有关的现金 | 6,342,039,605.65 | 5,542,039,776.83 | 3,673,726,378 | 2,061,558,156.5 |
| 经营活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
| 经营活动现金流出小计 | 42,050,816,226.45 | 33,465,920,804.63 | 24,764,029,766.59 | 13,061,958,705.86 |
| 经营活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
| 经营活动产生的现金流量净额 | 15,899,668,761.6 | 3,686,270,672.17 | 664,858,247.42 | 576,564,117.2 |
| 二、投资活动产生的现金流量: | | | | |
| 收回投资收到的现金 | 5,237,352,693.32 | 3,787,704,280.48 | 2,588,487,252.62 | 366,729,718.75 |
| 取得投资收益收到的现金 | 572,810,536.86 | 329,761,810.41 | 260,334,037.71 | 143,383,035.38 |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | 213,136.41 | 202,707.65 | 176,354.82 | 5,230 |
| 处置子公司及其他营业单位收到的现金净额 | 472,478,143.12 | 452,482,515.37 | 30,850,000 | 41,940,280.79 |
| 收到的其他与投资活动有关的现金 | 34,894,847.92 | 24,042,585.42 | 2,692,133.88 | - |
| 投资活动现金流入的平衡项目 | 0 | 0 | 0 | 0 |
| 投资活动现金流入小计 | 6,317,749,357.63 | 4,594,193,899.33 | 2,882,539,779.03 | 552,058,264.92 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 10,306,388,799.95 | 9,539,877,275.08 | 8,677,050,691.15 | 3,053,939,814.05 |
| 投资支付的现金 | 18,014,244,275.21 | 13,387,329,466.03 | 11,299,885,684.57 | 8,179,208,941.62 |
| 取得子公司及其他营业单位支付的现金 | 1,002,485,356.65 | 963,783,105.02 | 963,783,105.02 | 963,783,105.02 |
| 支付其他与投资活动有关的现金 | 376,158,986.77 | 376,558,986.77 | 41,940,280.79 | - |
| 投资活动现金流出的平衡项目 | 0 | 0 | 0 | 0 |
| 投资活动现金流出小计 | 29,699,277,418.58 | 24,267,548,832.9 | 20,982,659,761.53 | 12,196,931,860.69 |
| 投资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
| 投资活动产生的现金流量净额 | -23,381,528,060.95 | -19,673,354,933.57 | -18,100,119,982.5 | -11,644,873,595.77 |
| 三、筹资活动产生的现金流量: | | | | |
| 吸收投资收到的现金 | 9,794,184,988.5 | 7,223,702,588.5 | 7,169,484,007.65 | 1,979,800,000 |
| 其中:子公司吸收少数股东投资收到的现金 | 9,794,184,988.5 | 7,223,702,588.5 | 7,169,484,007.65 | 1,979,800,000 |
| 取得借款收到的现金 | 86,449,091,789.45 | 65,410,974,578.22 | 45,968,672,578.5 | 22,753,782,739.34 |
| 收到其他与筹资活动有关的现金 | 165,652,410.08 | 120,352,612.49 | 89,438,249.76 | 23,830,852.35 |
| 筹资活动现金流入平衡项目 | 0 | 0 | 0 | 0 |
| 筹资活动现金流入小计 | 96,408,929,188.03 | 72,755,029,779.21 | 53,227,594,835.91 | 24,757,413,591.69 |
| 偿还债务支付的现金 | 85,162,618,197.65 | 62,314,539,095.58 | 39,438,753,238.99 | 15,295,242,251.29 |
| 分配股利、利润或偿付利息支付的现金 | 8,450,755,077.96 | 6,347,372,737.29 | 3,359,194,720.58 | 1,760,145,015.33 |
| 其中:子公司支付给少数股东的股利、利润 | 313,536,725.51 | 99,990,000 | - | - |
| 支付其他与筹资活动有关的现金 | 8,214,902,113.16 | 4,525,714,970.78 | 4,270,826,480.38 | 808,738,800.07 |
| 筹资活动现金流出平衡项目 | 0 | 0 | 0 | 0 |
| 筹资活动现金流出小计 | 101,828,275,388.77 | 73,187,626,803.65 | 47,068,774,439.95 | 17,864,126,066.69 |
| 筹资活动产生的现金流量净额平衡项目 | 0 | 0 | 0 | 0 |
| 筹资活动产生的现金流量净额 | -5,419,346,200.74 | -432,597,024.44 | 6,158,820,395.96 | 6,893,287,525 |
| 四、汇率变动对现金及现金等价物的影响 | -2,753,890.91 | -8,877,985.04 | -2,293,331.48 | -5,148,991.2 |
| 现金及现金等价物净增加额平衡项目 | 0 | 0 | 0 | 0 |
| 五、现金及现金等价物净增加额 | -12,903,959,391 | -16,428,559,270.88 | -11,278,734,670.6 | -4,180,170,944.77 |
| 加:期初现金及现金等价物余额 | 45,469,395,750.01 | 45,469,395,750.01 | 45,469,395,750.01 | 45,469,395,750.01 |
| 期末现金及现金等价物余额平衡项目 | 0 | 0 | 0 | 0 |
| 期末现金及现金等价物余额 | 32,565,436,359.01 | 29,040,836,479.13 | 34,190,661,079.41 | 41,289,224,805.24 |
| 补充资料: | | | | |
| 净利润 | 1,404,559,755.51 | - | 1,734,751,595.77 | - |
| 资产减值准备 | 1,840,458,782.23 | - | - | - |
| 固定资产和投资性房地产折旧 | 224,935,967.18 | - | 114,025,979.24 | - |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 224,935,967.18 | - | 114,025,979.24 | - |
| 无形资产摊销 | 36,712,234.03 | - | 18,606,822.01 | - |
| 长期待摊费用摊销 | 49,386,396.13 | - | 32,917,280.76 | - |
| 处置固定资产、无形资产和其他长期资产的损失 | -3,524,145.38 | - | -58,821,761.86 | - |
| 固定资产报废损失 | 426,297.65 | - | 184,589.12 | - |
| 公允价值变动损失 | -353,616,298.61 | - | -21,006,975.89 | - |
| 财务费用 | 775,834,996.86 | - | 365,369,913.47 | - |
| 投资损失 | -889,990,249.06 | - | -209,648,464.02 | - |
| 递延所得税 | -830,097,410.25 | - | 517,105,321.05 | - |
| 其中:递延所得税资产减少 | -748,838,846.09 | - | 646,141,701.86 | - |
| 递延所得税负债增加 | -81,258,564.16 | - | -129,036,380.81 | - |
| 存货的减少 | 33,974,121,118.89 | - | 14,538,535,586.85 | - |
| 经营性应收项目的减少 | -1,972,031,057.15 | - | -3,941,535,702.67 | - |
| 经营性应付项目的增加 | -18,654,438,076.18 | - | -12,546,089,248.76 | - |
| 现金的期末余额 | 32,565,436,359.01 | - | 34,190,661,079.41 | - |
| 减:现金的期初余额 | 45,469,395,750.01 | - | 45,469,395,750.01 | - |
| 公告日期 | 2025-03-15 | 2024-10-30 | 2024-08-31 | 2024-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |